Advertisement

Topics

Auris Health, Inc. Company Profile

11:29 EDT 18th June 2018 | BioPortfolio

Based in Silicon Valley, Auris Health is pioneering the next era of medical intervention by developing platforms that enhance physician capabilities, evolve minimally invasive techniques, and create new categories of care that redefine optimal patient outcomes. The company is committed to transforming medical intervention by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform. Every element of our technology is driven by patient-specific design aimed at maintaining the integrity of the human body. The company is backed by leading technology investors including Mithril Capital Management, Lux Capital, Coatue Management, and Highland Capital. Learn more at www.aurishealth.com.


News Articles [357 Associated News Articles listed on BioPortfolio]

Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer

Auris Health is now the latest surgical robot company with the go-ahead to enter the U.S. market. The Redwood City, CA, based company, formerly known as Auris Surgical Robots, said Friday that its rob...

Auris Health, Neuwave enter development, commercialization deal

A cooperative development and commercialization deal was reached by Auris Health and Neuwave Medical, a unit of Johnson & Joh -More- 

FDA clears Auris' robotic endoscopy platform

The FDA gave Auris Health clearance for its Monarch robotic endoscopy platform for diagnostic and therapeutic bronchoscopic p -More- 

New failure for Auris in tinnitus trial

The future of Keyzilen, an in-ear injection being developed by Auris Medical Holding in acute inner ear…

Auris Health partners with Ethicon to allow Bronchoscopic ablation of lesions in lungs

Auris Health has signed a cooperative development and commercialization agreement with NeuWave Medical, a subsidiary of Ethicon and part of the Johnson & Johnson Medical Devices Companies, to enable r...

FDA Clears First Test for Emerging Pathogen Candida auris

The Bruker Maldi Biotyper CA system can reliably identify C auris 100% of the time. FDA Approvals

FDA Authorizes New Use of Test to Identify Emerging Pathogen Candida auris

The U.S. Food and Drug Administration authorized the first test to identify the emerging pathogen Candida auris (C. auris), which can cause serious infections in hospitalized patients.Contributed Auth...

Auris Medical News Release - Auris Medical to Provide Update on Its AM-111 Hearing Loss Program on Thursday, January 4, 2018

Zug, Switzerland, Dec. 28, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryn...

PubMed Articles [3693 Associated PubMed Articles listed on BioPortfolio]

Errata of Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.

Candida auris, which we described in 2009 (1), has become a global health threat (2). Due to the increasing interest in C. auris, we have received a number of questions regarding this topic. On re-exa...

Persistent Candidemia Despite Appropriate Fungal Therapy: First Case of Candida auris from the United Arab Emirates.

In this case, we report an elderly patient with multiple chronic conditions and prolonged intensive care units (ICU) stay who had recurrent Candida auris (C. auris) in blood despite antifungal therapy...

Candida auris.

To give an update on the recent emergence of Candida auris.

Five-year profile of candidemia at an Indian Trauma Center: high rates of Candida auris blood stream infections.

Candidemia is a potentially fatal infection with varied distribution of Candida species and their antifungal susceptibility profiles. The recent emergence of Candida auris in invasive candidiasis is a...

The first isolate of Candida auris in China: clinical and biological aspects.

The emerging human fungal pathogen Candida auris has been recognized as a multidrug resistant species and is associated with high mortality. This fungus was first described in Japan in 2009 and has be...

Clinical Trials [2794 Associated Clinical Trials listed on BioPortfolio]

Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.

To evaluate the efficacy and tolerability of Auris-Sedina in the symptomatic control of otalgy in patients with and without acute external otitis compared with use of Otosynalar®.

Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 in Patients With Candidiasis Caused by Candida Auris (CARES)

This is a multicenter, open-label, non-comparator, single-arm study to evaluate the efficacy, safety, tolerability and PK (pharmacokinetics) of oral SCY-078 as an emergency use treatment f...

Auris Robotic Endoscopy System for Bronchoscopy

In this study, the performance related to the use of the novel Robotic Endoscopy Platform during bronchoscopic procedures will be evaluated.

Trial Embedded in an Electronic Personal Medical Health Records

This is a research study to determine if a personal health record, called myHERO, will help improve health. A personal health record is a secure internet (also called online) tool that con...

Oral Health Literacy Tailored Communication

The purpose of this study to investigate attitude, oral health literacy and psychological factors in order to evaluate if these factors are important for oral health in adults. The hypoth...

Companies [1762 Associated Companies listed on BioPortfolio]

Auris Health, Inc.

Based in Silicon Valley, Auris Health is pioneering the next era of medical intervention by developing platforms that enhance physician capabilities, evolve minimally invasive tec...

Innovation Health

Innovation Health provides health benefit plans to more than 200,000 members. The product of a unique Aetna and Inova Health System partnership, Innovation Heal...

Health Net Foundation

Based in Woodland Hills, Calif., the Health Net Foundation was created in 2007 as a philanthropic arm of Health Net, Inc. (NYSE: HNT), one of the nation’s largest publicly tr...

Health Net Community Solutions, Inc. and CalViva Health

Health Net Community Solutions, Inc. is a subsidiary of Health Net of California, Inc., which is a subsidiary of Health Net, Inc. (NYSE: HNT) and one of the largest health plans i...

Network Health

Since 1997, Network Health has provided Massachusetts residents with low and moderate incomes access to high-quality health care. Based in Medford, Mass., Network Health is a comp...

More Information about "Auris Health, Inc." on BioPortfolio

We have published hundreds of Auris Health, Inc. news stories on BioPortfolio along with dozens of Auris Health, Inc. Clinical Trials and PubMed Articles about Auris Health, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Auris Health, Inc. Companies in our database. You can also find out about relevant Auris Health, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record